Cargando…

Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors

N(1)-methylnicotinamide (N(1)-MN) and N(1)-methyl-2-pyridone-5-carboxamide (2Py) are successive end products of NAD(+) catabolism. N(1)-MN excretion in 24-h urine is the established biomarker of niacin nutritional status, and recently shown to be reduced in renal transplant recipients (RTR). However...

Descripción completa

Detalles Bibliográficos
Autores principales: Deen, Carolien P. J., van der Veen, Anna, Gomes-Neto, António W., Geleijnse, Johanna M., Borgonjen-van den Berg, Karin J., Heiner-Fokkema, M. Rebecca, Kema, Ido P., Bakker, Stephan J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074074/
https://www.ncbi.nlm.nih.gov/pubmed/32041099
http://dx.doi.org/10.3390/jcm9020437
_version_ 1783506756281827328
author Deen, Carolien P. J.
van der Veen, Anna
Gomes-Neto, António W.
Geleijnse, Johanna M.
Borgonjen-van den Berg, Karin J.
Heiner-Fokkema, M. Rebecca
Kema, Ido P.
Bakker, Stephan J. L.
author_facet Deen, Carolien P. J.
van der Veen, Anna
Gomes-Neto, António W.
Geleijnse, Johanna M.
Borgonjen-van den Berg, Karin J.
Heiner-Fokkema, M. Rebecca
Kema, Ido P.
Bakker, Stephan J. L.
author_sort Deen, Carolien P. J.
collection PubMed
description N(1)-methylnicotinamide (N(1)-MN) and N(1)-methyl-2-pyridone-5-carboxamide (2Py) are successive end products of NAD(+) catabolism. N(1)-MN excretion in 24-h urine is the established biomarker of niacin nutritional status, and recently shown to be reduced in renal transplant recipients (RTR). However, it is unclear whether 2Py excretion is increased in this population, and, if so, whether a shift in excretion of N(1)-MN to 2Py can be attributed to kidney function. Hence, we assessed the 24-h urinary excretion of 2Py and N(1)-MN in RTR and kidney donors before and after kidney donation, and investigated associations of the urinary ratio of 2Py to N(1)-MN (2Py/N(1)-MN) with kidney function, and independent determinants of urinary 2Py/N(1)-MN in RTR. The urinary excretion of 2Py and N(1)-MN was measured in a cross-sectional cohort of 660 RTR and 275 healthy kidney donors with liquid chromatography-tandem mass spectrometry (LC-MS/MS). Linear regression analyses were used to investigate associations and determinants of urinary 2Py/N(1)-MN. Median 2Py excretion was 178.1 (130.3–242.8) μmol/day in RTR, compared to 155.6 (119.6–217.6) μmol/day in kidney donors (p < 0.001). In kidney donors, urinary 2Py/N(1)-MN increased significantly after kidney donation (4.0 ± 1.4 to 5.2 ± 1.5, respectively; p < 0.001). Smoking, alcohol consumption, diabetes, high-density lipoprotein (HDL), high-sensitivity C-reactive protein (hs-CRP) and estimated glomerular filtration rate (eGFR) were identified as independent determinants of urinary 2Py/N(1)-MN in RTR. In conclusion, the 24-h urinary excretion of 2Py is higher in RTR than in kidney donors, and urinary 2Py/N(1)-MN increases after kidney donation. As our data furthermore reveal strong associations of urinary 2Py/N(1)-MN with kidney function, interpretation of both N(1)-MN and 2Py excretion may be recommended for assessment of niacin nutritional status in conditions of impaired kidney function.
format Online
Article
Text
id pubmed-7074074
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70740742020-03-19 Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors Deen, Carolien P. J. van der Veen, Anna Gomes-Neto, António W. Geleijnse, Johanna M. Borgonjen-van den Berg, Karin J. Heiner-Fokkema, M. Rebecca Kema, Ido P. Bakker, Stephan J. L. J Clin Med Article N(1)-methylnicotinamide (N(1)-MN) and N(1)-methyl-2-pyridone-5-carboxamide (2Py) are successive end products of NAD(+) catabolism. N(1)-MN excretion in 24-h urine is the established biomarker of niacin nutritional status, and recently shown to be reduced in renal transplant recipients (RTR). However, it is unclear whether 2Py excretion is increased in this population, and, if so, whether a shift in excretion of N(1)-MN to 2Py can be attributed to kidney function. Hence, we assessed the 24-h urinary excretion of 2Py and N(1)-MN in RTR and kidney donors before and after kidney donation, and investigated associations of the urinary ratio of 2Py to N(1)-MN (2Py/N(1)-MN) with kidney function, and independent determinants of urinary 2Py/N(1)-MN in RTR. The urinary excretion of 2Py and N(1)-MN was measured in a cross-sectional cohort of 660 RTR and 275 healthy kidney donors with liquid chromatography-tandem mass spectrometry (LC-MS/MS). Linear regression analyses were used to investigate associations and determinants of urinary 2Py/N(1)-MN. Median 2Py excretion was 178.1 (130.3–242.8) μmol/day in RTR, compared to 155.6 (119.6–217.6) μmol/day in kidney donors (p < 0.001). In kidney donors, urinary 2Py/N(1)-MN increased significantly after kidney donation (4.0 ± 1.4 to 5.2 ± 1.5, respectively; p < 0.001). Smoking, alcohol consumption, diabetes, high-density lipoprotein (HDL), high-sensitivity C-reactive protein (hs-CRP) and estimated glomerular filtration rate (eGFR) were identified as independent determinants of urinary 2Py/N(1)-MN in RTR. In conclusion, the 24-h urinary excretion of 2Py is higher in RTR than in kidney donors, and urinary 2Py/N(1)-MN increases after kidney donation. As our data furthermore reveal strong associations of urinary 2Py/N(1)-MN with kidney function, interpretation of both N(1)-MN and 2Py excretion may be recommended for assessment of niacin nutritional status in conditions of impaired kidney function. MDPI 2020-02-06 /pmc/articles/PMC7074074/ /pubmed/32041099 http://dx.doi.org/10.3390/jcm9020437 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Deen, Carolien P. J.
van der Veen, Anna
Gomes-Neto, António W.
Geleijnse, Johanna M.
Borgonjen-van den Berg, Karin J.
Heiner-Fokkema, M. Rebecca
Kema, Ido P.
Bakker, Stephan J. L.
Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors
title Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors
title_full Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors
title_fullStr Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors
title_full_unstemmed Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors
title_short Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors
title_sort urinary excretion of n(1)-methyl-2-pyridone-5-carboxamide and n(1)-methylnicotinamide in renal transplant recipients and donors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074074/
https://www.ncbi.nlm.nih.gov/pubmed/32041099
http://dx.doi.org/10.3390/jcm9020437
work_keys_str_mv AT deencarolienpj urinaryexcretionofn1methyl2pyridone5carboxamideandn1methylnicotinamideinrenaltransplantrecipientsanddonors
AT vanderveenanna urinaryexcretionofn1methyl2pyridone5carboxamideandn1methylnicotinamideinrenaltransplantrecipientsanddonors
AT gomesnetoantoniow urinaryexcretionofn1methyl2pyridone5carboxamideandn1methylnicotinamideinrenaltransplantrecipientsanddonors
AT geleijnsejohannam urinaryexcretionofn1methyl2pyridone5carboxamideandn1methylnicotinamideinrenaltransplantrecipientsanddonors
AT borgonjenvandenbergkarinj urinaryexcretionofn1methyl2pyridone5carboxamideandn1methylnicotinamideinrenaltransplantrecipientsanddonors
AT heinerfokkemamrebecca urinaryexcretionofn1methyl2pyridone5carboxamideandn1methylnicotinamideinrenaltransplantrecipientsanddonors
AT kemaidop urinaryexcretionofn1methyl2pyridone5carboxamideandn1methylnicotinamideinrenaltransplantrecipientsanddonors
AT bakkerstephanjl urinaryexcretionofn1methyl2pyridone5carboxamideandn1methylnicotinamideinrenaltransplantrecipientsanddonors